Vanguard Group Inc Cara Therapeutics, Inc. Put Options Transaction History
Vanguard Group Inc
- $5.12 Trillion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding CARA
# of Institutions
84Shares Held
16.4MCall Options Held
55KPut Options Held
500-
Disciplined Growth Investors Inc Minneapolis, MN1.94MShares$600,0720.01% of portfolio
-
Chescapmanager LLC Baltimore, MD1.7MShares$527,6540.04% of portfolio
-
Farallon Capital Management LLC San Francisco, CA1.56MShares$482,4370.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.07MShares$330,3820.0% of portfolio
-
David A. Siegel Two Sigma Advisers, LP | New York, Ny862KShares$267,0960.0% of portfolio
About Cara Therapeutics, Inc.
- Ticker CARA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,725,900
- Market Cap $16.7M
- Description
- Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...